পদ্ধতির তুলনা করুন
নির্বাচিত পদ্ধতিগুলো পাশাপাশি পর্যালোচনা করুন; যে সারিগুলোয় পার্থক্য আছে সেগুলো চিহ্নিত করা হয়।
| ক্রনিক হার্ট ফেইলিওর প্রশ্নাবলী× | EORTC QLQ-C30× | |
|---|---|---|
| ক্ষেত্র | স্বাস্থ্য ফলাফল | স্বাস্থ্য ফলাফল |
| পরিবার | Process / pipeline | Process / pipeline |
| উদ্ভবের বছর≠ | 2000 | 1993 |
| প্রবর্তক≠ | Luc Guyonnet et al. | Nico Aaronson et al. |
| ধরন | Self-report quality of life questionnaire | Self-report quality of life questionnaire |
| মৌলিক উৎস≠ | Guyonnet, S., Vellas, B., Garry, P. J., & Albarede, J. L. (2000). The Chronic Heart Failure Questionnaire: A pilot study of validity, reliability, and responsiveness. Journal of Cardiac Failure, 6(1), 21-26. link ↗ | Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI ↗ |
| অপর নাম | CHQ, Heart Failure Quality of Life, Chronic Heart Failure QoL | QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale |
| সম্পর্কিত≠ | 4 | 5 |
| সারসংক্ষেপ≠ | The CHQ is a disease-specific quality of life measure for chronic heart failure (CHF). Developed by Luc Guyonnet and colleagues in 2000, this 20-item questionnaire assesses how heart failure affects dyspnea, fatigue, emotional function, and activity limitation. It is used in heart failure clinical trials and research to quantify patient-experienced burden and treatment benefit. | The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care. |
| ScholarGateডেটাসেট ↗ |
|
|